Last Wednesday, January 6, 2016, I had an opportunity to attend a presentation about NIH’s work with IBM’s Watson. Several groups at NIH have been exploring how Watson might benefit our operations and serve our intramural and extramural research communities. The presentation featured work that Mike Lauer, who is Deputy Director for Extramural Research, has been involved in.
The first example pertained to using Watson to do impact analyses of NIH funding. Our approach at the moment tends to be pretty crude, usually number of publications from a grant or initiative. Humans had determined that less than two-thirds of clinical trials at the National Heart Lung and Blood Institute had published results within 30 months after they were closed. They identified... Read more